Evaluation of the Immune Response to a 2-Dose Measles Vaccination Schedule Administered at 6 and 9 Months of Age to HIV-Infected and HIV-Uninfected Children in Malawi

Clicks: 189
ID: 114103
2008
Free PDF
Article Quality & Performance Metrics
Overall Quality Improving Quality
0.0 /100
Combines engagement data with AI-assessed academic quality
AI Quality Assessment
Not analyzed
Abstract
Abstract. Background. The World Health Organization recommends that infants at high risk for developing measles before 9 months of age, including human immunod
Reference Key
f.2008theevaluation Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Helfand, Rita F.;Witte, Desiree;Fowlkes, Ashley;Garcia, Philip;Yang, Chunfu;Fudzulani, Richard;Walls, Laura;Bae, Sun;Strebel, Peter;Broadhead, Robin;Bellini, William J.;Cutts, Felicity;
Journal The Journal of infectious diseases
Year 2008
DOI
DOI not found
URL
https://doi.org/10.1086%2F592756
Keywords
National Center for Biotechnology Information NCBI NLM MEDLINE humans pubmed abstract nih national institutes of health national library of medicine research support non-u.s. gov't female male Infant Randomized Controlled Trial Antibodies Measles Vaccine / administration & dosage* viral / blood hiv-1 / immunology hiv infections / immunology* measles vaccine / immunology* measles virus / immunology* kaplan-meier estimate measles / prevention & control* vaccination* malawi felicity cutts pmid:18828743 doi:10.1086/592756 rita f helfand desiree witte demography immunocompromised host / immunology

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.